Chronic obstructive pulmonary disease (COPD)
610 results
501 - 600
Procalcitonin reduces antibiotic prescribing for acute bronchitis but not other causes of lower respiratory tract infection
Benzodiazepines for the relief of breathlessness in advanced malignant and non‐malignant diseases in adults- Self‐management interventions for people with chronic obstructive pulmonary disease
- Once daily long‐acting beta2‐agonists and long‐acting muscarinic antagonists in a combined inhaler versus placebo for chronic obstructive pulmonary disease
Systemic corticosteroids for acute exacerbations of chronic obstructive pulmonary disease - Tiotropium Respimat has similar safety profile as HandiHaler
- Antibiotics for exacerbations of chronic obstructive pulmonary disease
- One year of once-daily doxycycline does not reduce exacerbation frequency in adults with moderate to severe COPD
- Psychological therapies for the treatment of depression in chronic obstructive pulmonary disease
- Oral corticosteroids for stable COPD
- Computer and mobile technology interventions for self‐management in chronic obstructive pulmonary disease
- Aclidinium bromide for stable chronic obstructive pulmonary disease
- Immunostimulants versus placebo for preventing exacerbations in adults with chronic bronchitis or chronic obstructive pulmonary disease
- Digital interventions for the management of chronic obstructive pulmonary disease
- Head‐to‐head oral prophylactic antibiotic therapy for chronic obstructive pulmonary disease
- Systemic corticosteroids for acute exacerbations of chronic obstructive pulmonary disease: Cochrane systematic review
- Tiotropium versus placebo for chronic obstructive pulmonary disease
- Long-acting beta2-agonists for poorly reversible chronic obstructive pulmonary disease: Cochrane systematic review
- Long‐acting beta2‐agonist in addition to tiotropium versus either tiotropium or long‐acting beta2‐agonist alone for chronic obstructive pulmonary disease
- Nutritional supplementation in stable chronic obstructive pulmonary disease
- Action plans with brief patient education for exacerbations in chronic obstructive pulmonary disease
- Inhaled corticosteroids with combination inhaled long‐acting beta2‐agonists and long‐acting muscarinic antagonists for chronic obstructive pulmonary disease
- Insomnia
- Tiotropium versus long‐acting beta‐agonists for stable chronic obstructive pulmonary disease
- Long‐acting muscarinic antagonist (LAMA) plus long‐acting beta‐agonist (LABA) versus LABA plus inhaled corticosteroid (ICS) for stable chronic obstructive pulmonary disease
- Fluticasone + salmeterol may reduce mortality but also increase pneumonia in COPD
- High-end normal bilirubin level associated with reduced risk of lung disease and mortality
- Combination inhaled steroid and long‐acting beta2‐agonist in addition to tiotropium versus tiotropium or combination alone for chronic obstructive pulmonary disease
- Noninvasive positive‐pressure ventilation as a weaning strategy for intubated adults with respiratory failure
- Neuromuscular electrostimulation for adults with chronic obstructive pulmonary disease
- Haemophilus influenzae vaccination for the prevention of acute exacerbations of chronic bronchitis
- Nocturnal oxygen for COPD patients who do not qualify for daytime oxygen is unlikely to be helpful (INOX)
- Chronic non‐invasive ventilation for chronic obstructive pulmonary disease
- Prophylactic antibiotics for adults with chronic obstructive pulmonary disease: a network meta‐analysis
- Noninvasive positive pressure ventilation as a weaning strategy for intubated adults with respiratory failure
- Pharmacological interventions for the treatment of depression in chronic obstructive pulmonary disease
- Respiratory failure
- Nutritional supplementation for stable chronic obstructive pulmonary disease: Cochrane systematic review
- Singing for children and adults with bronchiectasis: Cochrane systematic review
- Combined corticosteroid and long‐acting beta2‐agonist in one inhaler versus inhaled corticosteroids alone for chronic obstructive pulmonary disease
- Combined corticosteroid and long‐acting beta2‐agonist in one inhaler versus placebo for chronic obstructive pulmonary disease
- Upper limb exercise training for COPD
- Home versus center based physical activity programs in older adults
- Fewer exacerbations but somewhat more pneumonia with triple inhaler therapy for COPD (IMPACT)
- Tiotropium versus ipratropium for COPD
- Mucolytic agents for chronic bronchitis
- Pneumococcal vaccines for children and adults with bronchiectasis
- Inhaled corticosteroids in COPD
- Non‐invasive ventilation during exercise training for people with chronic obstructive pulmonary disease
- Corticosteroids for tuberculous pleurisy: Cochrane systematic review
- Integrated disease management interventions for patients with chronic obstructive pulmonary disease
- Decreased hospital LOS not associated with increase in 30-day readmission rates
- Long-acting beta-2 agonists for chronic obstructive pulmonary disease
- Beta2‐agonists for acute cough or a clinical diagnosis of acute bronchitis
- Pulmonary rehabilitation versus usual care for adults with asthma
- Combined corticosteroid and long‐acting beta2‐agonist in one inhaler versus long‐acting beta2‐agonists for chronic obstructive pulmonary disease
- Pulmonary function tests
- Short‐term ambulatory oxygen for chronic obstructive pulmonary disease
- Cardioselective betablockers in patients with reversible airway disease
- Antibiotics for exacerbations of chronic obstructive pulmonary disease
- Guidelines not helpful in patients with multiple conditions
- Prehospital emergency care
- Supplemental oxygen ineffective for COPD with moderate hypoxemia
- Treatment of acute exacerbation of asthma
- Non-pharmacological interventions for breathlessness in advanced stages of malignant and non-malignant diseases: Cochrane systematic review
- Inhaled steroids and risk of pneumonia for chronic obstructive pulmonary disease
- Prophylactic antibiotic therapy for chronic obstructive pulmonary disease
- Population-based case-finding intervention to identify undiagnosed COPD and asthma has minimal benefits
- Oxygen for breathlessness in patients with chronic obstructive pulmonary disease who do not qualify for home oxygen therapy
- Bronchoscopic lung volume reduction procedures for chronic obstructive pulmonary disease
- Non‐invasive ventilation for the management of acute hypercapnic respiratory failure due to exacerbation of chronic obstructive pulmonary disease
- Bronchodilators delivered by nebuliser versus pMDI with spacer or DPI for exacerbations of COPD
- Palliative treatment
- Long‐acting inhaled therapy (beta‐agonists, anticholinergics and steroids) for COPD: a network meta‐analysis
- Intravenous alpha‐1 antitrypsin augmentation therapy for treating patients with alpha‐1 antitrypsin deficiency and lung disease
- Multimodal interventions for cachexia management
- Triple inhaled therapy provides a small reduction in moderate exacerbations, no effect on severe exacerbations (ETHOS)
- Bronchiectasis
- Temperature-induced skin disorders
- Antidepressants for depression in physical illness
- Non-invasive positive pressure ventilation for treatment of respiratory failure due to severe acute exacerbations of asthma: Cochrane systematic review
- Speech and language therapy for management of chronic cough
- Influenza
- Self‐management for bronchiectasis
- Alpha‐2 agonists for long‐term sedation during mechanical ventilation in critically ill patients
- Interventions for fatigue and weight loss in adults with advanced progressive illness